The first affiliated hospital of Anhui Medical University
Hefei, Anhui, 230000, China
NCT Number: NCT02871193
The procedures of thoracotomy are among the most painful operations. In addition to post-thoracotomy pain, the outcomes of surgery are affected adversely by postoperative discomfort. Therefore, post-thoracotomy pain control can improve the satisfaction of patient and prevent postoperative complications such as pneumonia, atelectasis, or respiratory failure. Thoracic epidural analgesia (TEA) used to be widely considered as a standard technique for providing analgesia after a thoracotomy. However, TEA carries side-effects such as incomplete or failed block, epidural hematoma, abscess, hypotension, respiratory depression, or bradycardia, etc. Recently, thoracic paravertebral block (TPVB) is an alternative technique for TEA that may offer a comparable analgesic effect and a better side -effect profile for post-thoracotomy analgesia. When local anesthetic agents are used as single injection, they can provide analgesia for limited period. Various adjuvants have been tried in the past in order to enhance the duration and quality of postoperative analgesia. Previous studies with perineural dexamethasone demonstrated that it enhanced the duration of local anesthetic block. The mechanism of its action is blocking the nociceptive impulse transmission along the myelinated C fibers. Patient-controlled analgesia (PCA) devices have been shown to provide superior analgesia and greater patient satisfaction compared with intermittent administration. System of wire-less PCA provides remote monitoring, information management and PCA devices with high precision. The purpose of this research is to determine whether dexamethasone might prolong the duration of analgesia and improve the short-time outcomes when administered for TPVB along with local anesthetic agents in elective thoracotomy.
Looking for future studies?
Notify Me19 year–80 year
All sexes
Interventional
Not applicable
Hefei, Anhui, 230000, China
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
ultrasound-guided thoracic paravertebral nerve block (TPVB) with 0.5% ropivacaine 20ml
Other names: ropivacaine hydrochloride
ultrasound-guided thoracic paravertebral nerve block (TPVB) with 0.5% ropivacaine 20ml and dexamethasone 5 mg
Other names: dxm, dex
ultrasound-guided thoracic paravertebral nerve block (TPVB) with 0.9% saline 20ml
Other names: normal saline
Time frame: 6 hours,12hours,24hours and 72hours after operation
to show the grading of pain in different groups after surgery
Time frame: 6hours,12hours,24hours and 72hours after operation
to show the consumption of analgesics after surgery
Time frame: 24 hours after anesthesia
To show the changing trend of hemodynamics with different treatment-related events when receiving thoracotomy.
Time frame: 24 hours after surgery
to show the quality of recovery
Time frame: 24 hours after surgery
to show the quality of recovery
Time frame: 3days after operation
To compare the incidence rates of side effects, such as nausea, vomiting, dizziness, hypotension and bradyarrhythmia in the first 3 days after operation.
Time frame: 30 days after surgery
To compare the incidence rates of complications, such as pneumonia, atelectasis, respiratory failure, heart failure, etc
Time frame: 30 days after surgery
The First Affiliated Hospital of Anhui Medical University
Other
Study of Ultrasound-guided Thoracic Paravertebral Block Using Ropivacaine With/Without Dexamethasone in Elective Thoracotomy
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06993740
Anesthesia, Cardiovascular Diseases
Jakarta, DKI Jakarta, Indonesia
View Trial DetailsNCT05320718
Anesthesia, Local, Regional Anesthesia
Beijing, Beijing Municipality, China
View Trial DetailsNCT05552092
Surgery
Gwangju, South Korea
View Trial DetailsNCT03369210
Anemia, Hematologic Diseases
Aachen, Germany
View Trial Details